395 related articles for article (PubMed ID: 16095872)
1. Differential effects on [35S]GTPgammaS binding using muscarinic agonists and antagonists in the gerbil brain.
Pilar-Cuéllar F; Paniagua MA; Mostany R; Pérez CC; Fernández-López A
J Chem Neuroanat; 2005 Oct; 30(2-3):119-28. PubMed ID: 16095872
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic receptor changes in the gerbil thalamus during aging.
Pilar-Cuéllar F; Paniagua MA; Díez-Alarcia R; Dos Anjos S; Montori S; Pérez CC; Fernández-López A
Brain Res; 2008 Dec; 1243():38-46. PubMed ID: 18835552
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
4. Segment-dependent activation of muscarinic acetylcholine receptor-mediated [35S]Guanosine-5'-O-(gamma-thiotriphosphate) binding in airway tissue membranes.
Hajek P; Ungemach FR; Abraham G
Pharmacology; 2009; 83(4):247-58. PubMed ID: 19295255
[TBL] [Abstract][Full Text] [Related]
5. Role of muscarinic receptors, G-proteins, and intracellular messengers in muscarinic modulation of NMDA receptor-mediated synaptic transmission.
Aramakis VB; Bandrowski AE; Ashe JH
Synapse; 1999 Jun; 32(4):262-75. PubMed ID: 10332802
[TBL] [Abstract][Full Text] [Related]
6. The muscarinic M(4) receptor is the functionally predominant subtype in rat and mouse striatum as demonstrated using [(35)S] GTPγS binding.
Chapman KL; Vaswani D; Hendry N; Langmead CJ; Kew JN; Watson JM
Eur J Pharmacol; 2011 Feb; 652(1-3):1-6. PubMed ID: 21114972
[TBL] [Abstract][Full Text] [Related]
7. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P
J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767
[TBL] [Abstract][Full Text] [Related]
8. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
9. A high n-6 polyunsaturated fatty acid diet reduces muscarinic M2/M4 receptor binding in the rat brain.
du Bois TM; Bell W; Deng C; Huang XF
J Chem Neuroanat; 2005 Jun; 29(4):282-8. PubMed ID: 15927789
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue.
Salah-Uddin H; Thomas DR; Davies CH; Hagan JJ; Wood MD; Watson JM; Challiss RA
J Pharmacol Exp Ther; 2008 Jun; 325(3):869-74. PubMed ID: 18322150
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex.
Onali P; Olianas MC
J Pharmacol Exp Ther; 1998 Aug; 286(2):753-9. PubMed ID: 9694930
[TBL] [Abstract][Full Text] [Related]
12. Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes.
Zhang HM; Chen SR; Pan HL
J Neurophysiol; 2007 Jan; 97(1):102-9. PubMed ID: 17050831
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).
Olianas MC; Maullu C; Adem A; Mulugeta E; Karlsson E; Onali P
Br J Pharmacol; 2000 Oct; 131(3):447-52. PubMed ID: 11015294
[TBL] [Abstract][Full Text] [Related]
14. Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.
Salah-Uddin H; Scarr E; Pavey G; Harris K; Hagan JJ; Dean B; Challiss RA; Watson JM
Neuropsychopharmacology; 2009 Aug; 34(9):2156-66. PubMed ID: 19404243
[TBL] [Abstract][Full Text] [Related]
15. Functional activity of the M2 and M4 receptor subtypes in the spinal cord studied with muscarinic acetylcholine receptor knockout mice.
Chen SR; Wess J; Pan HL
J Pharmacol Exp Ther; 2005 May; 313(2):765-70. PubMed ID: 15665136
[TBL] [Abstract][Full Text] [Related]
16. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
17. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.
Jakubík J; El-Fakahany EE; Dolezal V
Mol Pharmacol; 2006 Aug; 70(2):656-66. PubMed ID: 16675658
[TBL] [Abstract][Full Text] [Related]
18. Detection of cannabinoid CB1, adenosine A1, muscarinic acetylcholine, and GABA(B) receptor-dependent G protein activity in transducin-deactivated membranes and autoradiography sections of rat retina.
Savinainen JR; Laitinen JT
Cell Mol Neurobiol; 2004 Apr; 24(2):243-56. PubMed ID: 15176438
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic characterisation of [35S]GTPgammaS binding stimulation mediated by 5-HT1B receptor in postmortem human brain.
Mostany R; Pazos A; Castro ME
Neuropharmacology; 2005 Jan; 48(1):25-33. PubMed ID: 15617724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
